Purpose: To explore morphologic characteristics of choroidal lesions in patients with disseminated Mycobacterium chimaera infection subsequent to open-heart surgery.
R ecently, Mycobacterium chimaera, a slowly growing nontuberculous mycobacterium, has attracted attention because of a global health care-associated outbreak of invasive infections after cardiothoracic surgery. 1 Currently, over 100 patients from more than 10 countries have been reported to suffer from invasive M. chimaera infection. [2] [3] [4] [5] [6] These infections resulted from aerosolized M. chimaera originating from water tanks of heater cooler units used in cardiovascular surgery with extracorporeal circulation for heating/cooling purposes. 1 Because this disease entity is still relatively unknown, misdiagnosing of clinical signs seems probable and the actual prevalence of M. chimaera infection may be substantially higher. 4 Clinical and histopathological findings of five patients with ocular M. chimaera infection have been described recently. 7 All five patients presented with chorioretinal lesions and a subset of patients had additional signs of mild anterior uveitis, intermediate uveitis, or disc swelling. During follow-up, the number of chorioretinal lesions was progressive in three of five patients despite extensive antimicrobial therapy and three of five patients died from complications of disseminated M. chimaera infection.
Because of growing relevance of this health carerelated infection, we herein aim to characterize choroidal lesions in disseminated M. chimaera infection of nine patients through multimodal imaging.
We reviewed differences between active and inactive ocular findings. We also tested the hypothesis that these lesions were related to the systemic affection and sought relationships to systemic disease activity and therapy.
Materials, Subjects, and Methods

Case Detection
Methods of case finding and detection have been described previously. 1, 2, 7 Briefly, patients had undergone open-heart surgery and have subsequently been diagnosed with M. chimaera infection based on either positive mycobacterial tissue cultures, 16SrRNA PCR, or mycobacterial blood cultures. Ocular findings were collected at baseline of M. chimaera diagnosis and during prospective follow-up. For the current study, ophthalmologic findings of the patients treated at the University Hospital Zurich were completed, and supplemented by four additional cases of disseminated M. chimaera infections with ocular involvement from the University Hospital Basel. Institutional review board approval was obtained and all patients provided informed consent to publish their clinical data.
Clinical Aspects
Patients with disseminated M. chimaera infection were initially treated with a 4-or 5-fold tuberculostatic therapy containing clarithromycin, ethambutol, rifabutin, and moxifloxacin ± amikacin with the goal of an early redo surgery with replacement of all cardiac foreign material if possible (Table 1) . At the time of redo surgery and during clinical follow-up, blood and tissue cultures for mycobacteria were obtained. Systemic disease activity was defined as new positive blood cultures for mycobacteria and/or new positive mycobacterial cultures from a normally sterile site either while on tuberculostatic therapy (breakthrough infection) or in the posttreatment period (relapse).
Assessment of Ocular Findings and Acquisition of Multimodal Imaging Findings
Patients underwent a complete ophthalmologic examination including biomicroscopy, color fundus photography with ultra-widefield photography using Optomap scanning laser ophthalmoscope (Optos, Marlborough, MA), spectral domain optical coherence tomography (OCT) including enhanced depth imaging (EDI) technique, fundus autofluorescence (FAF) imaging, fluorescein angiography/indocyanine green angiography (FA/ICGA) and, where possible, OCT angiography (OCTA). The widefield angiograms were either obtained using the Optomap system or the ultrawidefield module for the Heidelberg SPECTRALIS HRA + OCT. 8 The spectral domain OCTs and EDIOCTs were obtained using the Heidelberg SPECTRA-LIS (version 1.9.10.0) as viewed with the contained Heidelberg software (Spectralis Viewing Module 6.0.9.0; Heidelberg Engineering, Heidelberg, Germany). In this study, at least 31 B-scans were obtained within a 20°· 25°rectangle centered on the macula; however, the scan pattern was adapted according to the location and the size of the lesions. Choroidal imaging was obtained using the same instrument in the EDI mode. 9 Fundus autofluorescence images were obtained in all patients using the confocal scanning laser ophthalmoscope (Heidelberg Retinal Angiograph, HRA2; Heidelberg Engineering). Optical coherence tomography angiography images were obtained using PLEX Elite 9000 swept-source OCT (Carl Zeiss Meditec, Inc., Dublin, CA) with OMAGc algorithm. 10 The scan area for this study was a 12 mm · 12 mm scan centered on the fovea and around the posterior pole to create a widefield montage image obtained with each cube consisting of 2 repeated volumes of 500 B-scans. We used the preset segmentation of the viewing software to extract the outer retina/choriocapillaris slab, which extends from 110 mm above retinal pigment epithelium (RPE) to 38 mm below RPE. In case of neovascular lesions, we used, in addition, a 3 · 3 scan centered on the lesion and we included the outer retina slab to better detect the neovascular membrane located above the RPE.
After diagnosis of ocular involvement, eye examinations were warranted every 3 to 4 months or more frequently if required, including regular multimodal imaging acquisition. Three readers (C.B., S.A.Z., and M.A.-S.) reviewed the spectrum of imaging findings in all cases. "Progressive ocular disease" was defined as occurrence of two or more new chorioretinal lesions per eye if they were not present in previous examinations and/or enlargement of previously existing choroidal lesions. The time between diagnosis of "progressive ocular disease" and "active systemic disease" †Systemic disease activity was defined as new positive blood cultures for mycobacteria and/or new positive mycobacterial cultures from a normally sterile site either while on tuberculostatic therapy (breakthrough infection) or in the posttreatment period (relapse).
was assessed. For classification of uveitis, criteria of the Standardization of Uveitis Nomenclature Working Group were applied. 11 Enhanced depth imaging OCT scans over the choroidal lesions were evaluated regarding full thickness/partial thickness, shape, reflectivity, internal pattern, margins, and hypertransmission. In adddition, the presence of any fluid was noted using spectral domain OCT. The en face image of the choriocapillaris was used to visualize the lesions. The OCTA image was registered to the ICGA image using the publically available ImageJ software (public domain software; National Institutes of Health, Bethesda, MD) as described previously. 12 For this purpose, the choriocapillaris OCTA image and the ICGA were registered to each other using vascular bifurcation in the superficial plexus as landmark to align the two images for accurate comparison. Changes in the choriocapillaris/inner choroid perfusion were identified. Presence of a neovascular flow/membrane in the avascular outer retina and/or sub-RPE space was evaluated.
Results
Patient Characteristics
Nine white patients (18 eyes) aged between 49 and 66 years were diagnosed with either endocarditis and/ or aortic graft infection with M. chimaera after a cardiothoracic surgery with extracorporeal circulation. All patients had a negative serology for HIV. All eyes had bilateral chorioretinal lesions. Applicable patient numbers were maintained according to previous publications. 2, 7 Table 1 shows clinical characteristics of each patient including medical and surgical treatment. Mean ophthalmologic follow-up was 17.6 months. All nine patients were discovered prospectively by screening patients with known infections. At baseline, two patients reported blurred vision, whereas seven patients had no visual symptoms. During follow-up, two initially symptom-free patients described decreased vision and blurriness correlating with progressive ocular findings. Morphology of the chorioretinal lesions in these patients are described in more detail by assessing each imaging technique separately.
Multimodal Imaging Findings of Choroidal Lesions
Fundus photography. Despite the fact that all patients had chorioretinal lesions as seen using fundus Fig. 2 . Progression from inactive to active ocular disease in disseminated M. chimaera infection. A-C. Fundus photography (A, right eye; B, left eye) and indocyanine green angiography (C, left eye) of a 50-year-old patient who was diagnosed ad redo surgery. Few clinically inactive lesions were observed to be stable for over 20 months. Systemic antimycobacterial therapy was stopped after 24 months as the infection was deemed clinically inactive. D-F. The same patient was hospitalized 15 months later due to worsening hepatic function consistent with atypical mycobacteremia and consecutively diagnosed with a relapse based on positive mycobacterial blood cultures. In conjunction with the relapse, progression of choroidal lesions was observed. G-I. Five months later, despite systemic antimycobacterial treatment, more lesions became clinically evident. photography or using biomicroscopy, the extent of these lesions varied widely. At baseline, four patients had only a very few inactive (2-5/eye) choroidal lesions (mild ocular abnormalities). During follow-up, five patients (10 eyes) developed widespread lesions (progressive ocular disease). The lesions had typically a round or ovoid shape (Figures 1-4) . Figure 1 shows an exemplary overview of active ocular disease in different patients using different multimodal imaging methods. Although these white-yellowish lesions were usually small (50-300 mm diameter), their size was observed to increase over weeks in active disease. An example of progressive disease over time is shown in Figure 2 . Furthermore, indistinct borders on fundus photography represented a sign of activity, whereas inactivity or quiescence was related to well-defined borders of the lesions ( Table 2 ). The largest lesion in the cohort had a diameter of 2,700 mm ( Figure 5 ). In patients with progressive ocular disease, the number of lesions was increasing over 4 to 8 weeks and lesions were ultimately distributed diffusely over both the posterior pole and the retinal periphery. All five patients with new lesions and, therefore, active ocular disease also showed atrophic lesions suggesting formerly active lesions (Figure 1 ). Active and inactive lesions could be observed in close proximity in the same eye. In 3 of 5 patients with progressive ocular disease, we were able to detect a stable period with clinically inactive lesions over at least 6 months before progression to active ocular disease.
Fluorescein angiography. Active choroidal lesions in all five patients with progressive disease were initially hypofluorescent on FA, with staining in the later frames (Figures 1 and 4) . However, early phase of FA showed hyperfluorescence of inactive lesions with hyperfluorescence in late phase according to a window defect. In two patients (four eyes) with progressive disease, FA also indicated a mild optic disk leakage. Otherwise, no obvious angiographic features could be observed. No eye had signs of retinal vasculitis, of capillary nonperfusion, or of cystoid macular edema.
Indocyanine green angiography. By ICGA, there were multiple hypocyanescent lesions, which were found to be hypocyanescent in both early and late frames. As compared to other means of investigation, the lesions detected on ICGA outnumbered the lesions detected on fundus photography or FA by .5 per eye in all 10 eyes with progressive disease (Figures 2 and  4) . In all cases, ICGA was, therefore, superior to fundus photography for assessing occurrence of new (A and D) , the borders of the lesion on EDI-OCT were found to be relatively well-defined because there usually was an intense homogenously hyporeflective area (arrows). G. Note the borders of this inactive lesion, which were poorly defined (arrowheads).
lesions. Large active lesions showed a longer and stronger hypocyanescence in the late phase of the IC-GA than inactive lesions. However, even after more than 6 months' duration, lesions still showed a faint hypocyanescence. Complete regression of the hypocyanescent areas was not observed, even in clinically quiet and sharply demarcated lesions on fundus photography, which could be explained because of atrophy of the choriocapillaris/stromal choroid.
Fundus autofluorescence. Using FAF, active chorioretinal lesions presented as hyperautofluorescent areas in all five patients with progressive disease (Figure 1 ). In the inactive status of the lesion, they appeared typically hypoautofluorescent. Frequently, new active hyperautofluorescent lesions could be observed close to atrophic hypoautofluorescent lesions. Lesions in the very late stages often showed a confluent hypoautofluorescence indicating confluent loss of RPE cells. Between lesions, the FAF was found to be normal without presence of pathologic hyperautofluorescence or hypoautofluorescence. However, lesions on FAF were outnumbered by lesions found on ICGA by .5 per eye in all cases with progressive disease. (Figure 3) . The borders of active lesions on EDI-OCT were found to be relatively well defined as there usually was an intense homogenously hyporeflective area. Inactive lesions did not always correlate with a substantial hyporeflective area. Therefore, the borders of inactive lesions were generally poorly defined (Figure 3 ). Fullthickness lesions were shown to affect the adjacent RPE, in such as that the latter was attenuated and irregularly shaped. Smaller, partial-thickness lesions were also present in at least some cases, but because of the smaller size, they were more difficult to verify. Hypertransmission was observed in both inactive and active lesions (Figure 3) . Enhanced depth imaging OCT revealed that even alterations of the integrity of the ellipsoid zone were present over choroidal lesions (Figure 3 ). The size of active lesions was observed to decrease over time, whereas new lesions developed near the latter lesion. One progressively large granuloma has led to a Type 2 macular neovascularization with development of subretinal fluid above the chorioretinal lesion ( Figure 5 ).
Optical coherence tomography angiography. Optical coherence tomography angiography was performed In the OCTA including the en face image of the choriocapillaris and the avascular outer retina, neovascular flow with small-and medium-caliber vessels with branching of tiny vessels and arcades at the vessel termini (A) was observed. The right image shows the lesion 4 weeks after treatment with anti-VEGF. Note the reduced retinal thickness on the structural OCT, the decreased hyperreflective material, and the reduced area of the neovascular lesion (white arrows, B).
in one patient with progressive disease and in three patients with mild ocular disease. In progressive disease, the choriocapillaris/inner choroid en face OCTA image showed a flow reduction in the area that corresponded to the detected lesions on ICGA (Figure 4) . Interestingly, the lesions detected by OCTA also outnumbered those found by both fundus photography and FA. The en face and cross-sectional OCTA image of a patient who reported blurry vision showed neovascular flow overlying a large chorioretinal lesion involving the posterior pole. The subretinal hyperreflective material (SHRM) detected on the structural OCT corresponded with neovascular flow presented on the en face OCTA image of the avascular outer retina/choriocapillaris ( Figure 6 ). Morphologically, the lesions showed small-and medium-caliber vessels with branching of tiny vessel and arcades at the vessel termini. Intravitreal anti-vascular endothelial growth factor (anti-VEGF) treatment was performed, leading to marked regression of the neovascularization activity. Best-corrected visual acuity in the affected eye increased from 20/25 before therapy to 20/20 after treatment. The follow-up visit 4 weeks after anti-VEGF therapy showed a reduced retinal thickness, decreased SHRM, and reduced area and density of the neovascular membrane. Table 1 shows relationships between ocular and systemic disease for each patient. In five of nine patients, progression of the number and size of choroidal lesions was observed despite being under systemic antimicrobial therapy. As of September 2017, 3 of these 5 patients have died because of systemic complications, potentially related to uncontrolled M. chimaera infection. 2, 7 In four patients with progressive disease, redo surgery was either not performed or performed very late in the disease process or parts of the cardiovascular materials were retained (Cases 2, 4, 5, and 6). In one patient (Case 8), a breakthrough infection (positive blood cultures, new mycobacterial spinal lesions) was diagnosed 8 months after redo surgery and ongoing antimicrobial therapy. All 5 patients had evidence of systemic disease activity within ±6 weeks before or after the diagnosis of progressive choroiditis. In three patients, the ocular progression preceded systemic disease activity, whereas in two patients, systemic disease activity was diagnosed before ocular progression.
Relationship to Systemic Disease Activity
Discussion
Choroidal manifestation seems to be an accessible indicator of systemic disease activity in patients with disseminated M. chimaera infection. This study highlights the description and evolution of the chorioretinal lesions using various multimodal imaging techniques. Two particular aspects of ocular involvement were the uniform distribution and the extensive number of choroidal lesions despite antimycobacterial treatment. Monitoring disease activity in patients with disseminated M. chimaera disease should not be based on color fundus photography or biomicroscopy alone. Indocyanine green angiography is superior to assess the occurrence of new lesions, whereas EDI-OCT is suitable to visualize details of the choroidal lesions. Multimodal imaging is helpful for classifying lesions as active or inactive, for assessing the response to antimicrobial treatment, and for detecting early subclinical recurrences.
Enhanced depth imaging OCT allows for an assessment of structural choroidal abnormalities. In patients with M. chimaera infection, EDI-OCT scanning nicely indicated the size and the extent of hyporeflective lesions. The normal choroidal vascularity was markedly reduced in the affected area and we were able to demonstrate that clinically active lesions were mostly involving the full choroidal thickness extending from the back of the RPE to the choroidoscleral border. However, the lesions are generally not limited to the choroidal space, but often affect the RPE and sometimes also the outer retinal layers. These hyporeflective areas became less prominent over time and the initial homogenous hyporeflectivity gradually decreased. Histopathological investigation of these lesions in one affected subject revealed local granulomatous inflammation. 7 The presence of mycobacteria has also been hypothesized, but could not be proven, probably because of their fastidious growth.
Although EDI-OCT was suitable to monitor selected lesions, imaging with ICGA enabled a better global visualization of lesions, including central and peripheral areas. Hypocyanescent lesions on ICGA outnumbered lesions on fundus photography and on FAF, indicating that only a subset of the total choroidal lesions were either large enough or localized close enough to the RPE to be visualized by photography or FAF. These spots could result from blockage by the lesions themselves, from choroidal hypoperfusion or from displacement of vessels by spaceoccupying lesions. Under systemic anti-infective therapy, some lesions were observed to become less hypocyanescent but they did not completely disappear. However, this change is not proven to be treatment related and might also reflect disease evolution. Because all patients with active disease were systemically treated, the clinical course of active lesions without treatment is not clear. Our data showed that regression of one single lesion did not necessarily correlate with the overall disease control because sometimes new lesions developed in the proximity and significantly increased in size. This might be explained by recurrent bacteremia that led to new lesions, whereas older ones were becoming smaller and atrophic after a few weeks under treatment.
The biomicroscopic presentation of the chorioretinal lesions in our series was similar to that of multifocal choroiditis related to ocular tuberculosis. [13] [14] [15] [16] [17] [18] [19] However, besides similarities there also seem to be differences between the two entities. The M. chimaerarelated lesions were all roundish, whereas the chorioretinal lesions in tuberculosis are generally more variable in shape. Fundus imaging of ocular tuberculosis may show a more irregularly distribution compared with the picture in M. chimaera infection. Also, although there is a large spectrum of findings in ocular tuberculosis, none of the patients in these series presented with other findings potentially suggestive of tuberculosis such as nodular scleritis, interstitial keratitis, synechia, severe vitritis, serpiginoid choroiditis, or retinal vasculitis. 19 Choroidal lesions observed in tuberculosis usually resolve under systemic treatment over a few weeks, with residual scarring. 18, 20 However, nontuberculous mycobacterium infections in and around the eye are clinically recalcitrant and may require long-term therapy and removal of biomaterials. 21 M. chimaera-related choroiditis has not been described specifically before this current outbreak. However, other atypical mycobacteria have been reported to cause choroiditis, namely in HIV-positive patients. 22, 23 Bhikoo et al have described such a case of multifocal choroiditis in an HIV patient with disseminated M. avium complex infection. The choroidal lesions in this subject were larger compared with the lesions in our HIV-negative M. chimaera patients. Multifocal choroiditis has also been reported as initial manifestation of disseminated cryptococcal infection. 24 Andreola et al 25 have described Cryptococcus neoformans infection and multifocal choroiditis in an HIV patient, which led to blindness. The clinical presentation in these cases was similar as the multifocal choroiditis in patients with M. chimaera infection.
The development of choroidal neovascularization (CNV) in the setting of an active granuloma is intriguing. Although infrequently, CNV has been reported in eyes with infectious chorioretinitis including tuberculosis, toxoplasmosis, syphilis, presumed ocular histoplasmosis syndrome, and Bartonella henselae. [26] [27] [28] [29] [30] [31] [32] However, in most of these cases, CNV presented not during the acute inflammatory process, but later in the setting of a chorioretinal scar. The differentiation between inflammatory-related structural alterations and neovascular lesions presenting as SHRM is by spectral domain OCT usually difficult and may result in delayed treatment. Optical coherence tomography angiography, a relatively new noninvasive technique, permits detection of vascular flow/networks relative to tissue depth and allows to distinguish vascular and avascular SHRM. 33 In our patient, neovascular flow in the subretinal space located over the granuloma could be clearly demonstrated on OCTA despite minimal leakage on FA. Optical coherence tomography angiography allowed not only to detect but also to monitor the response to treatment in disseminated M. chimaera infection with NV.
During prospective follow-up of these nine patients, we have observed progression in five patients and activation of previously inactive ocular disease in at least three patients so far. Because ocular disease likely reflects systemic disease activity, monitoring is highly recommended (Table 3) . To provide accurate care, we herein propose baseline and follow-up eye examinations for patients at risk of M. chimaera infection. These recommendations were based on our observations including the aforementioned relationships between ocular and systemic progression and the fact that new lesions developed within 4 to 8 weeks. The generalizability of these recommendations is limited by the fact that this infection is overall uncommon and clinical experience is scarce. The low incidence of this infection also explains the relatively small sample size, which is a limitation of the study. The followup duration differs between patients and longer observation periods may show different or new insights. Interpretation of relationships between ocular and systemic findings is confounded by temporary diagnostic windows of both ophthalmologic imaging findings and systemic activity signs such as blood cultures.
In conclusion, in patients with bilateral multifocal choroiditis and a history of cardiothoracic surgery, disseminated M. chimaera infection should be suspected. Differentiating between active and inactive ocular disease by multimodal imaging is important because of the likely association with systemic disease activity. Thorough clinical examination, fundus photography, and EDI-OCT can detect the presence of active chorioretinal lesions, whereas FA and especially ICGA reveal the total lesion number and are better suited to detect overall disease progression. Optical coherence tomography angiography showed flow reduction at the level of choriocapillaris/inner choroid that corresponded to the lesions detected on ICGA. Whether this finding represents hypoperfusion of the choriocapillaris or displacement of the capillaries by space-occupying lesions needs to be investigated in the future. Furthermore, analysis of en face OCTA and cross-sectional OCTA images enabled detection of neovascular flow secondary to CNV and its response to treatment with anti-VEGF.
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†In case of suggestive findings of ocular M. chimaera infection, interdisciplinary management is crucial and involvement of an infectious diseases' specialist is warranted.
